Skip to main content

Main menu

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

User menu

Subscribe
My alerts
Log in
My Cart

Search

Search for this keyword

Advanced search

SNMMI
- JNM
- JNMT
- SNMMI Journals
- SNMMI

Subscribe
My alerts
Log in
My Cart

Search for this keyword

Advanced Search

Home
Content
Subscriptions
Authors
Info
About
More
- Alerts
- Feedback
- Help
- SNMMI Journals

Follow JNM on Twitter
Visit JNM on Facebook
Join JNM on LinkedIn
Subscribe to our RSS feeds

Table of Contents

December 1, 2022; Volume 63,Issue 12

Author index is not available for this issue.

In this issue

Journal of Nuclear Medicine: 63 (12)

Journal of Nuclear Medicine

Vol. 63, Issue 12

December 1, 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Issue highlights

Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy

Search for this keyword

Sign up for alerts

Most Cited
Most Read

First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
Fibroblast Activation Protein–Targeted PET/CT with ⁶⁸Ga-FAPI for Imaging IgG4-Related Disease: Comparison to ¹⁸F-FDG PET/CT

© 2023 Journal of Nuclear Medicine